Canopy Growth Corporation

TSX:WEED.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.72 +2.26%

+$0.03 today

Market cap
$323.72M
Beta
2.41
P/E (TTM)
-1.8
EPS (TTM)
-$0.76
52W Low $1.18High $3.28

Volume 1.16M

Average 2.07M

WEED.TO Stock-Based Compensation

Employee pay granted in shares or options; a non-cash expense that dilutes existing shareholders.

Canopy Growth CorporationTSX: WEED.TO

Stock-Based Compensation · Q4 FY2025 · quarter ended Mar 2026

Stock-based compensation turns positive

Q4 FY2025 stock-based compensation was CA$1.47M, compared with -CA$18.74M a year earlier. Trailing-twelve-month stock-based compensation was CA$5.06M. Over 3 fiscal years it compounded at -44.8% a year.

Context

  • Stock-based compensation amounted to 1.5% of revenue in FY2025, unchanged from a year earlier.
  • Stock-based compensation increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly stock-based compensation holds near CA$1.47M or moves back toward the trailing-twelve-month quarterly average of CA$1.26M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$1.47M+65.3% QoQ
Last fiscal yearMar 2026
CA$4.27M+201.5% YoY
LTMMar 2026
CA$5.06M+220.3% YoY
Stock-Based Compensation past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+107.8%——
1 year+201.5%——
3-year CAGR-44.8%——
5-year CAGR——
10-year CAGR——

Stock-Based Compensation history

CAD · from the cash flow

Latest · FY2025
4.27M CAD
Year-over-year change
+201.5%
4-year CAGR
-45.0%

Stock-Based Compensation vs competitors

How WEED.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so stock-based compensation is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +220.3% is the highest of 8, against a peer median of -10.1%.
  • Stock-based compensation amounts to 1.6% of revenue for WEED.TO, versus a peer median of 3.0%.
WEED.TO Competitors
Stock-Based Compensation for WEED.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$7.29M CAD-36.7%-24.4%2.3%
FRX.TOFennec Pharmaceuticals Inc.LTM Mar 2026$7.23M USD+54.8%+18.6%14.1%
WEED.TOCanopy Growth CorporationLTM Mar 2026CA$5.06M CAD+220.3%-44.8%1.6%
XLY.TOAuxly Cannabis Group Inc.LTM Mar 2026CA$4.81M CAD+5.0%+9.4%3.0%
TSND.TOTerrAscend Corp.LTM Mar 2026$4.38M USD-55.0%-25.6%1.7%
OGI.TOOrganiGram Holdings Inc.LTM Mar 2026CA$3.45M CAD-36.6%—1.3%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$2.48M CAD-10.1%+21.0%89.8%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$1.8M USD+64.7%+62.8%3.5%
Peer median (excluding WEED.TO) —-10.1%+14.0%3.0%

Competitors are the stored peer set for WEED.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Mar 2022
FY2022
Mar 2023
FY2023
Mar 2024
FY2024
Mar 2025
FY2025
Mar 2026
Net Income(320.49M)(723.36M)(483.68M)(604.14M)(262.91M)
Depreciation & Amortization114.42M80.03M53.18M43.12M36.47M
Deferred Income Tax(8.95M)(5.73M)12.33M7.14M23K
Stock-Based Compensation46.69M25.32M14.18M(4.21M)4.27M
Change in Working Capital165.56M65.85M(38.69M)(41.36M)27.38M
Accounts Receivables13.6M(9.91M)(3.75M)(4.49M)25.69M
Inventory173.19M55.64M1.03M(17.72M)3.71M
Accounts Payables(35.84M)17.63M9.12M(15.48M)(4.35M)
Other Working Capital14.61M2.48M(45.09M)(3.68M)2.34M
Other Non-Cash Items(543.88M)339K160.74M433.7M130.96M
Operating Cash Flow(545.81M)(557.55M)(281.95M)(165.75M)(63.81M)
Capital Expenditures(48.11M)(10.55M)(4M)(11.28M)(5.95M)
Acquisitions (Net)103.2M(9.29M)(955K)(6.97M)(41.54M)
Purchases of Investments(379.41M)(67.15M)(347K)(95.34M)0
Sales of Investments545.99M502.59M78.55M16.43M19M
Other Investing Activities9.15M17.79M167.38M48.9M6.52M
Investing Cash Flow230.82M433.38M241.59M(47.79M)(21.35M)
Debt Repayment(50.76M)16.98M(509.78M)(220.78M)(13.52M)
Common Stock Issued2.7M1.05M81.06M385.39M374.17M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities2.53M(37.72M)(36.34M)(15.96M)(28.24M)
Financing Cash Flow(45.53M)(19.69M)(465.06M)148.66M332.41M
Effect of Forex Changes(18.12M)44.86M(1.29M)8.39M3.62M
Net Change in Cash(378.65M)(99M)(506.71M)(56.49M)250.87M
Free Cash Flow(593.92M)(568.1M)(285.95M)(177.03M)(69.76M)

Canopy Growth Corporation

TSX:WEED.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.72

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.